AVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Avnet (AVT) is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock is in an ongoing cyclical recovery, analysts have turned more constructive with multiple price target raises, and the technical trend remains bullish overall despite short-term momentum weakening. Since the user is unwilling to wait for an ideal entry, the current price near 88 still looks acceptable versus revised targets around 95-96. I would rate it a buy rather than a hold or sell.
AVT is in a generally bullish trend: SMA_5 is above SMA_20, which is above SMA_200, confirming a positive longer-term structure. RSI_6 at 60.731 is neutral-to-healthy and not overbought. The MACD histogram is -0.191 and negatively expanding, which signals some short-term momentum loss. Price closed at 88.02, above the pivot at 85.41 and approaching first resistance at 89.054, with next resistance at 91.306. Overall, the trend is constructive, but near-term upside may be somewhat choppy after the recent run.
["BofA upgraded Avnet to Neutral from Underperform and raised target to $96, citing constructive cycle indicators.", "Raymond James raised target to $95 and kept Strong Buy, pointing to continued recovery across regions and improving fundamentals.", "Truist raised target to $95 and kept Buy, citing meaningful upside and better-than-consensus guidance.", "Industry commentary suggests lead times are extending and shortages are starting, which supports distribution companies like Avnet.", "No recent negative news in the last week.", "No notable insider or hedge fund selling trend; trading activity is neutral rather than negative."]
["MACD histogram is below zero and worsening, showing short-term momentum deterioration.", "No recent news catalysts were reported in the last week, so there is no fresh near-term event to drive an immediate breakout.", "Hedge fund and insider trading trends are neutral, so there is no strong smart-money buying signal.", "Stock trend estimates show only moderate near-term upside rather than a sharp move."]
The latest quarter financial data was not available due to an error in the snapshot, so a detailed quarter-by-quarter financial review cannot be completed. However, analyst commentary indicates March quarter results showed continued recovery across regions and end markets, with demand broadening over multiple quarters, supporting margin expansion. The latest cited season is the March quarter, and guidance was described as well above consensus, which is a positive sign for recent operating performance.
Analyst sentiment has improved meaningfully over the last month. BofA upgraded AVT to Neutral from Underperform and raised its target to $96. Raymond James raised its target to $95 and maintained Strong Buy. Truist raised its target to $95 and kept Buy, after previously upgrading it to Buy from Hold with a target of $80. Wall Street’s pros view is clearly constructive, centered on cyclical recovery, improving demand, and margin expansion. The main con is that sentiment is now more positive than before, so some of the upside may already be partially priced in.
